A Case Note on Boehringer Ingelheim Pharma GMBH vs Vee Excel Drugs and Pharmaceuticals Private Ltd. & Ors judgement

In a judgment pronounced on 29.03.2023, titled Boehringer Ingelheim Pharma GMBH vs Vee Excel Drugs and Pharmaceuticals Private Ltd. & Ors, the Hon’ble Delhi High Court has denied interim injunction to Boehringer Ingelheim for the drug Linagliptin, holding that the patent IN 301 (species patent) is vulnerable to challenge.

Read More